Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Heartnut (Juglans ailantifolia var. cordiformis) is a heart-shaped walnut relative exceptionally rich in α-linolenic acid (ALA), γ-tocopherol (20.8–26.0 mg/100 g), and ellagitannin polyphenols that activate the Nrf2/ARE antioxidant pathway and suppress NF-κB-mediated inflammation, conferring potent cardioprotective and neuroprotective effects. A comprehensive review by Alasalvar and Bolling (2015, PMID 26148924) confirmed that Juglandaceae nuts including heartnut deliver among the highest γ-tocopherol and polyunsaturated fatty acid concentrations of any tree nut, with ellagitannins that gut microbiota convert to bioactive urolithins linked to reduced oxidative stress, improved lipid profiles, and lower cardiovascular disease risk.
Reported Benefits (Provisional)
Origin & History
Heartnut (Juglans ailantifolia var. cordiformis) is native to the temperate regions of Japan, where it thrives in rich, well-drained soils. This unique, heart-shaped nut is prized for its exceptional nutritional profile, offering significant benefits for cardiovascular, cognitive, and metabolic health.
Research Narrative (Provisional)
Alasalvar and Bolling (2015) published a landmark systematic review in the British Journal of Nutrition (PMID 26148924) analyzing nut phytochemicals, fat-soluble bioactives, antioxidant components, and health effects across the Juglandaceae family, which includes heartnuts. The review documented that walnuts and closely related species such as heartnut contain exceptionally high γ-tocopherol levels (20.8–26.0 mg/100 g), abundant ellagitannins and ellagic acid, and a polyunsaturated fatty acid profile dominated by α-linolenic acid—an omega-3 precursor linked to reduced cardiovascular risk markers. The authors concluded that regular consumption of Juglandaceae nuts is associated with improved lipid profiles, reduced inflammation biomarkers (including C-reactive protein and IL-6), and lower overall oxidative stress as measured by ORAC and FRAP assays. While heartnut-specific clinical trials remain limited, its phytochemical profile closely mirrors that of the English and Persian walnuts extensively studied in the review, supporting the translational relevance of these findings.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Healthy Fats (oleic acid, alpha-linolenic acid/omega-3): Promote cardiovascular wellness and reduce systemic inflammation. - Complete Plant-Based Protein: Offers all essential amino acids for muscle repair and cognitive vitality. - Vitamin E (Tocopherols): Supports antioxidant defenses and skin health. - Essential Minerals (magnesium, potassium, calcium, iron, zinc): Enhance bone density, cardiovascular wellness, and enzymatic activity. - Polyphenols and Flavonoids: Boost antioxidant and anti-inflammatory protection.
Reported Mechanism (Provisional)
Heartnut ellagitannins undergo hydrolysis in the gastrointestinal tract by gut microbiota—particularly Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens—to yield ellagic acid and bioactive urolithins (primarily urolithin A), which scavenge reactive oxygen species (ROS) and upregulate phase II detoxification enzymes such as heme oxygenase-1 (HO-1), NAD(P)H:quinone oxidoreductase 1 (NQO1), and glutathione S-transferases via activation of the Nrf2/Keap1/ARE signaling axis. Simultaneously, urolithin A and γ-tocopherol inhibit the NF-κB/IκB kinase pathway, reducing transcription of pro-inflammatory mediators including TNF-α, IL-1β, IL-6, and cyclooxygenase-2 (COX-2). The high α-linolenic acid (ALA) content serves as a substrate for elongation to eicosapentaenoic acid (EPA) via Δ6-desaturase, promoting biosynthesis of anti-inflammatory resolvins and protectins while competitively displacing arachidonic acid from membrane phospholipids to reduce pro-inflammatory eicosanoid production. γ-Tocopherol additionally traps reactive nitrogen species (peroxynitrite, NO₂) more effectively than α-tocopherol, providing complementary nitrosative stress protection in vascular endothelium.
Clinical Narrative (Provisional)
Current evidence is limited to preclinical studies, with no specific human clinical trials on heartnut reported in the literature. In vitro studies using walnut phenolic extract at concentrations >75 μg/mL showed complete protection of cell viability against 200 μM hydrogen peroxide exposure. Cell culture studies demonstrated reduced LDH leakage and ROS production, with urolithin A showing peak activity at 10 μM concentration. Clinical research is needed to establish therapeutic dosages and quantified health outcomes in human subjects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.